InvestorsHub Logo
Followers 6
Posts 201
Boards Moderated 0
Alias Born 10/11/2016

Re: None

Thursday, 04/09/2020 9:54:15 AM

Thursday, April 09, 2020 9:54:15 AM

Post# of 233718
Unless NP is using hyperbole, this is the most telling statement to me. There are emergency requests for Lero that cannot be met because the FDA won't allow them. Unless this logjam breaks up Cytodyn won't be nearly as successful as we hope it will.

"Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, “We are very pleased that leronlimab appears to facilitate an immunological restoration in these patients and we are sharing our data with the FDA in order to hopefully accelerate the access of our drug to many more patients in need. With more than 20 EINDs approved by the FDA, we are receiving an overwhelming number of EIND requests from all over the country.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News